Reduced apelin levels in lone atrial fibrillation

87Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Aims: Apelin is an endogenous peptide hormone that appears to have a physiological role in counter-regulation of the angiotensin and vasopressin systems. This peptide has been reported to be down-regulated in subjects with acute heart failure, but has not been studied in other cardiovascular conditions. We studied apelin levels in 73 subjects with lone atrial fibrillation (AF). Methods and results: Study subjects had electrocardiographic evidence of paroxysmal or chronic AF and a structurally normal heart on echocardiography. Subjects were excluded if they had a history of coronary artery disease, rheumatic heart disease, cardiomyopathy, significant valvular disease, hyperthyroidism, or antecedent hypertension. Controls were recruited from a healthy outpatient population. Plasma apelin levels were determined using a commercially available immunoassay. Seventy-three subjects with lone AF and 73 healthy controls were enrolled and studied. Mean levels of apelin were significantly lower in subjects with lone AF when compared with controls (307 vs. 648 pg/mL, P < 0.00005). Conclusion: Reduced apelin levels were observed in this homogenous population of lone AF subjects and may represent an underlying diathesis predisposing to this common arrhythmia. © The European Society of Cardiology 2005. All rights reserved.

Cite

CITATION STYLE

APA

Ellinor, P. T., Low, A. F., & MacRae, C. A. (2006). Reduced apelin levels in lone atrial fibrillation. European Heart Journal, 27(2), 222–226. https://doi.org/10.1093/eurheartj/ehi648

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free